Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EBEV: Bevacizumab vs Triamcinolone for Uveitic Macular Edema
NCT01095809Phase 3Terminated
- Sponsor
- Hospital Clínic de Barcelona
- Start
- Apr 2010
- Primary completion
- Apr 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of bevacizumab in uveitic macular edema (UME), sponsored by Hospital Clínic de Barcelona. Started Apr 2010; status: terminated.
02
Drugs
bevacizumab
03
Conditions
uveitic macular edema (UME)
Beyond the preview
Go deeper on NCT01095809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01095809.